Who Gets Chemotherapy for Metastatic Lung Cancer?

Reis, 1999 Ihde, 1992, Chemotherapy of Lung Cancer, N Engl J Med, 327, 1434, 10.1056/NEJM199211123272006 DeVita, 1993 Non-small Cell Lung Cancer Collaborative Group, 1995, Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials, BMJ, 311, 899, 10.1136/bmj.311.7010.899 Ruckdeschel, 1990, Is chemotherapy for metastatic nonsmall-cell lung cancer “worth it” [editorial]?, J Clin Oncol, 8, 1293, 10.1200/JCO.1990.8.8.1293 Tannock, 1990, When is cancer treatment worthwhile [editorial]?, N Engl J Med, 323, 989, 10.1056/NEJM199010043231410 American Society of Clinical Oncology, 1997, Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer, J Clin Oncol, 15, 2996 Lopez, 1997, Chemotherapy in stage IV (metastatic) non-small-cell lung cancer, Cancer Prev Control, 1, 18 Ettinger, 1996, NCCN non-small-cell lung cancer practice guidelines, Oncology, 10, 81 Smith, 1995, Differences in initial treatment patterns and outcomes of lung cancer in the elderly, Lung Cancer, 13, 235, 10.1016/0169-5002(95)00496-3 Greenberg, 1988, Social and economic factors in the choice of lung cancer treatment: a population-based study in two rural states, N Engl J Med, 318, 612, 10.1056/NEJM198803103181006 Zippin, 1995, Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute, Cancer, 76, 2343, 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-# Ries, 1997 Nattinger, 1997, Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research, J Clin Epidemiol, 50, 939, 10.1016/S0895-4356(97)00099-1 Potosky, 1993, Potential for cancer related health services research using a linked Medicare-tumor registry database, Med Care, 31, 732, 10.1097/00005650-199308000-00006 Charlson, 1986, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Charlson, 1986, Morbidity during hospitalization: can we predict it?, J Chronic Dis, 40, 705, 10.1016/0021-9681(87)90107-X Deyo, 1992, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases, Clin Epidemiol, 45, 613, 10.1016/0895-4356(92)90133-8 Klabunde, 1998 Krieger, 1992, Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology, Am J Pub Health, 92, 703, 10.2105/AJPH.82.5.703 Greenberg, 1988, Referral of lung cancer patients to university hospital cancer centers: a population-based study in two rural states, Cancer, 62, 1647, 10.1002/1097-0142(19881015)62:8<1647::AID-CNCR2820620832>3.0.CO;2-T Hillner, 1998, A comparison of patterns of care of nonsmall cell lung carcinoma patients in a younger and Medigap commercially insured cohort, Cancer, 83, 1930, 10.1002/(SICI)1097-0142(19981101)83:9<1930::AID-CNCR8>3.0.CO;2-X Kesson, 1998, Lung cancer management and outcome in Glasgow, 1991–92, Br J Cancer, 78, 1391, 10.1038/bjc.1998.690 Raby, 1995, Does knowledge guide practice?, Another look at the management of non-small-cell lung cancer J Clin Oncol, 13, 1904 Crook, 1997, Survey on the treatment of non-small cell lung cancer (NSCLC) in England and Wales, Eur Respir J, 10, 1552, 10.1183/09031936.97.10071552 Rapp, 1988, Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: report of a Canadian multicenter randomized trial, J Clin Oncol, 6, 633, 10.1200/JCO.1988.6.4.633 Quoix, 1991, La chimiotherapie comportant du cisplatin est-elle utile dans le cancer bronchique non microcellulaire au stade IV? Resultats d'une etude randomisee, Bull Cancer, 78, 341 Cellerino, 1991, A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small cell lung cancer, J Clin Oncol, 9, 1453, 10.1200/JCO.1991.9.8.1453 The Elderly Lung Cancer Vinorelbine Italian Study Group, 1999, Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer, J Natl Cancer Inst, 91, 66, 10.1093/jnci/91.1.66 Hynes, 1994, The quality of breast cancer care in local communities: implications for health care reform, Med Care, 32, 328, 10.1097/00005650-199404000-00002 Fireman, 1997, Cost of care for cancer in a Health Maintenance Organization, Health Care Financ Rev, 18, 51 Ayanian, 1996, Variations in breast cancer treatment by patient and provider characteristics, Breast Cancer Res Treat, 40, 65, 10.1007/BF01806003 Desch, 1996, Factors that determine the treatment for local and regional prostate cancer, Med Care, 34, 152, 10.1097/00005650-199602000-00007 Bennett, 1991, Patterns of care related to age of men with prostate cancer, Cancer, 67, 2633, 10.1002/1097-0142(19910515)67:10<2633::AID-CNCR2820671039>3.0.CO;2-9 Hillner, 1996, Variation in staging and treatment of local and regional breast cancer in the elderly, Breast Cancer Res Treat, 40, 75, 10.1007/BF01806004 Goel, 1997, Patterns of initial management of node-negative breast cancer in two Canadian provinces, Can Med Assoc J, 156, 25 Ruckdeschel, 1986, A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer, J Clin Oncol, 4, 14, 10.1200/JCO.1986.4.1.14 Extermann, 1998, Comorbidity and functional status are independent in older cancer patients, J Clin Oncol, 16, 1582, 10.1200/JCO.1998.16.4.1582 Ballard-Barbash, 1996, Factors associated with surgical and radiation therapy for early stage breast cancer in older women, J Natl Cancer Inst, 88, 716, 10.1093/jnci/88.11.716 Schulman, 1999, The effect of race and sex on physicians' recommendations for cardiac catheterization, N Engl J Med, 340, 618, 10.1056/NEJM199902253400806 Ayanian, 1991, Differences in the use of procedures between women and men hospitalized for coronary heart disease, N Engl J Med, 325, 221, 10.1056/NEJM199107253250401 Ganz, 1993, Age and gender as factors in cancer therapy, Clin Geriatr Med, 9, 145, 10.1016/S0749-0690(18)30428-2 Michalski, 1997, The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries, Cancer, 79, 314, 10.1002/(SICI)1097-0142(19970115)79:2<314::AID-CNCR14>3.0.CO;2-3 Ayanian, 1993, Racial differences in the use of revascularization procedures after coronary angiography, JAMA, 269, 2642, 10.1001/jama.1993.03500200056033 Ball, 1996, Treatment differences between blacks and whites with colorectal cancer, Med Care, 34, 970, 10.1097/00005650-199609000-00008 Burns, 1996, Black women receive less mammography even with similar use of primary care, Ann Intern Med, 125, 173, 10.7326/0003-4819-125-3-199608010-00002 Klabunde, 1998, Trends and black/white differences in treatment for nonmetastatic prostate cancer, Med Care, 36, 1337, 10.1097/00005650-199809000-00006 Hislop, 1996, Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia, Can J Public Health, 87, 390 Lantz, 1998, Socioeconomic factors, health behaviors, and mortality, JAMA, 279, 1703, 10.1001/jama.279.21.1703 Lipworth, 1963, Case-fatality in teaching and non-teaching hospitals, 1956–1959, Med Care, 1, 71, 10.1097/00005650-196304000-00005 Farrow, 1992, Geographic variation in the treatment of localized breast cancer, N Engl J Med, 326, 1097, 10.1056/NEJM199204233261701 Guadagnoli, 1995, Variation in the use of cardiac procedures after acute myocardial infarction, N Engl J Med, 333, 573, 10.1056/NEJM199508313330908 Guadagnoli, 1995, The influence of race on the use of surgical procedures for treatment of peripheral vascular disease of the lower extremities, Arch Surg, 130, 381, 10.1001/archsurg.1995.01430040043006 Lu-Yao, 1994, Changes in prostate cancer incidence and treatment in USA, Lancet, 343, 251, 10.1016/S0140-6736(94)91109-6 Weeks, 1996, Outcomes research studies, Oncology, 10, 29 Epstein, 1988, The association of patients' socioeconomic characteristics with the length of hospital stay and hospital charges within diagnosis-related groups, N Engl J Med, 318, 1579, 10.1056/NEJM198806163182405 Dayal, 1985, Race, socioeconomic status, and other prognostic factors for survival from prostate cancer, J Natl Cancer Inst, 74, 1001 Whittle, 1991, Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly Americans, Med Care, 29, 1226, 10.1097/00005650-199112000-00005 Riley, 1999, Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison, JAMA, 281, 720, 10.1001/jama.281.8.720 Frey, 1992, Representativeness of the Surveillance, Epidemiology, and End Results program data: recent trends in cancer mortality rates, J Natl Cancer Inst, 84, 872, 10.1093/jnci/84.11.872 Riley, 1994, Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees, Am J Public Health, 84, 1598, 10.2105/AJPH.84.10.1598